S9.3d Antivirulence drug discovery to disarm Candida albicans with metabolites from myxobacteria.

S9.3 DRUG RESISTANCE IN EMERGING PATHOGENIC FUNGI, SEPTEMBER 23, 2022, 4:45 PM - 6:15 PM: Candida albicans is an opportunistic fungal pathogen. While nearly 40%-60% of humans are colonized harmlessly by C. albicans, prolonged use of antibiotics or an immune-compromised status can lead to mucosal or...

Descripción completa

Detalles Bibliográficos
Autores principales: Vij, Raghav, Tröger, Sophie, Walt, Christine, Haeckl, F.P. Jake, Müller, Rolf, Kniemeyer, Olaf, Brakhage, Axel, Hube, Bernhard, Brunke, Sascha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511645/
http://dx.doi.org/10.1093/mmy/myac072.S9.3d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511645/
http://dx.doi.org/10.1093/mmy/myac072.S9.3d

Ejemplares similares